Victory Capital Management Inc Allogene Therapeutics, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 17,379 shares of ALLO stock, worth $35,974. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,379

Previous 17,697 1.8%

Holding current value

$35,974

Previous $41,000 17.07%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$2.08 - $3.5 $661 - $1,113	-318 Reduced 1.8%	17,379 $48,000
Q2 2024 Aug 05, 2024	BUY	$2.23 - $4.38 $8,969 - $17,616	4,022 Added 29.41%	17,697 $41,000
Q1 2024 May 03, 2024	SELL	$2.92 - $5.63 $1,775 - $3,423	-608 Reduced 4.26%	13,675 $61,000
Q4 2023 Feb 05, 2024	BUY	$2.28 - $3.5 $6,110 - $9,380	2,680 Added 23.1%	14,283 $45,000
Q3 2023 Nov 06, 2023	BUY	$3.17 - $5.96 $36,781 - $69,153	11,603 New	11,603 $36,000
Q2 2022 Aug 01, 2022	BUY	$6.78 - $12.28 $1,288 - $2,333	190 Added 1.33%	14,525 $166,000
Q1 2022 May 04, 2022	BUY	$7.65 - $15.29 $12,913 - $25,809	1,688 Added 13.35%	14,335 $120,000
Q4 2021 Feb 07, 2022	SELL	$13.13 - $24.52 $4,766 - $8,900	-363 Reduced 2.79%	12,647 $189,000
Q3 2021 Nov 02, 2021	SELL	$21.01 - $27.64 $992,890 - $1.31 Million	-47,258 Reduced 78.41%	13,010 $334,000
Q2 2021 Aug 03, 2021	SELL	$23.49 - $35.8 $20.9 Million - $31.8 Million	-888,591 Reduced 93.65%	60,268 $1.57 Million
Q1 2021 May 04, 2021	SELL	$25.79 - $39.02 $1.73 Million - $2.62 Million	-67,193 Reduced 6.61%	948,859 $33.5 Million
Q4 2020 Feb 01, 2021	SELL	$25.24 - $43.45 $4.94 Million - $8.5 Million	-195,611 Reduced 16.14%	1,016,052 $25.6 Million
Q3 2020 Nov 09, 2020	BUY	$32.38 - $44.96 $4.64 Million - $6.44 Million	143,215 Added 13.4%	1,211,663 $45.7 Million
Q2 2020 Aug 07, 2020	BUY	$18.39 - $54.04 $19.5 Million - $57.2 Million	1,058,279 Added 10406.91%	1,068,448 $45.8 Million
Q1 2020 May 04, 2020	SELL	$18.22 - $28.25 $39,992 - $62,008	-2,195 Reduced 17.75%	10,169 $198,000
Q4 2019 Feb 06, 2020	BUY	$24.82 - $31.4 $33,457 - $42,327	1,348 Added 12.24%	12,364 $321,000
Q4 2019 Feb 04, 2020	BUY	$24.82 - $31.4 $56,142 - $71,026	2,262 Added 25.84%	11,016 $239,000
Q3 2019 Nov 12, 2019	BUY	$26.11 - $32.99 $228,566 - $288,794	8,754 New	8,754 $239,000

Others Institutions Holding ALLO

# of Institutions

162

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $298M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Allogene Therapeutics, Inc. Transaction History